A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

Ralph P. Insinga, Cédric Joyal, Alexandra Goyette, André Galarneau

ABSTRACT

BACKGROUND: The objective of this analysis is to explore potential impact on operating room (OR) efficiency and incidence of residual neuromuscular blockade (RNMB) with use of sugammadex (Bridion™, Merck & Co., Inc., Kenilworth, NJ USA) versus neostigmine for neuromuscular block reversal in Canada. METHODS: A discrete event simulation (DES) model was developed to compare ORs using either neostigmine or sugammadex for NMB reversal over one month. Selected inputs included OR procedure and turnover times, hospital policies for paid staff overtime and procedural cancellations due to OR time over-run, and reductions in RNMB and associated complications with sugammadex use. Trials show sugammadex's impact on OR time and RNMB varies by whether full neuromuscular recovery (train-of-four ratio ≥0.9) is verified prior to extubation in the OR. Scenarios were therefore evaluated reflecting varied assumptions for neuromuscular reversal practices. RESULTS: With use of moderate neuromuscular block, when full neuromuscular recovery is verified prior to extubation (93 procedures performed with sugammadex, 91 with neostigmine), use of sugammadex versus neostigmine avoided 2.4 procedural cancellations due to OR time over-run and 33.5 h of paid staff overtime, while saving an average of 62 min per OR day. No difference was observed between comparators for these endpoints in the scenario when full neuromuscular recovery was not verified prior to extubation, however, per procedure risk of RNMB at extubation was reduced from 60% to 4% (reflecting 51 cases prevented), with associated reductions in risks of hypoxemia (12 cases avoided) and upper airway obstruction (23 cases avoided). Sugammadex impact in reversing deep neuromuscular block was evaluated in an exploratory analysis. When it was hypothetically assumed that 30 min of OR time were saved per procedure, the number of paid hours of staff over-time dropped from 84.1 to 32.0, with a 93% reduction in the per patient risk of residual blockade. CONCLUSIONS: In clinical practice within Canada, for the majority of patients currently managed with moderate neuromuscular block, the principal impact of substituting sugammadex for neostigmine is likely to be a reduction in the risk of residual blockade and associated complications. For patients maintained at a deep level of block to the end of the procedure, sugammadex is likely to both enhance OR efficiency and reduce residual block complications. More... »

PAGES

114

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12871-016-0281-3

DOI

http://dx.doi.org/10.1186/s12871-016-0281-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1049426690

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27852231


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Canada", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Computer Simulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Efficiency, Organizational", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neostigmine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuromuscular Blockade", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Operating Rooms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organizational Policy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sugammadex", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "gamma-Cyclodextrins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "MSD (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417993.1", 
          "name": [
            "Department of Predictive & Economic Modeling, Merck & Co., Inc, PO Box 1000, UG1CD-32, 19454-1099, North Wales, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Insinga", 
        "givenName": "Ralph P.", 
        "id": "sg:person.01254476051.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254476051.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Merck (Canada)", 
          "id": "https://www.grid.ac/institutes/grid.292545.d", 
          "name": [
            "Department of Health Economics and Observational Research, 16750 Transcanada Highway, Merck Canada, H9H 4M7, Kirkland, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joyal", 
        "givenName": "C\u00e9dric", 
        "id": "sg:person.0702677613.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702677613.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Merck (Canada)", 
          "id": "https://www.grid.ac/institutes/grid.292545.d", 
          "name": [
            "Department of Health Economics and Observational Research, 16750 Transcanada Highway, Merck Canada, H9H 4M7, Kirkland, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goyette", 
        "givenName": "Alexandra", 
        "id": "sg:person.012600665431.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012600665431.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Merck (Canada)", 
          "id": "https://www.grid.ac/institutes/grid.292545.d", 
          "name": [
            "Department of Medical Affairs, 16750 Transcanada Highway, Merck Canada, H9H 4M7, Kirkland, Qu\u00e9bec, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galarneau", 
        "givenName": "Andr\u00e9", 
        "id": "sg:person.013376246031.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013376246031.79"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.1365-2044.2005.04235.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001422224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2044.2005.04235.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001422224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/eja.0000000000000010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002676609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/eja.0000000000000010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002676609"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/0019-5049.108562", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005043142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181ac53c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005859806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181ac53c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005859806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181ac53c3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005859806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1399-6576.1997.tb04851.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009014306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/eja.0b013e32833d56b7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011166407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/eja.0b013e32833d56b7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011166407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bja/ael386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011356812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1590/s0104-11692011000500023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012264683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000237296.57941.e7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012778108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000237296.57941.e7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012778108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181da832d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013533672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181da832d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013533672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181da832d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013533672"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aco.0b013e32833a5413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016295960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aco.0b013e32833a5413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016295960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2012.08.1364", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023587552"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000542-199301000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025374245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000542-199301000-00010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025374245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mjt.0000000000000103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025735765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mjt.0000000000000103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025735765"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200969070-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028465269", 
          "https://doi.org/10.2165/00003495-200969070-00008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003495-200969070-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028465269", 
          "https://doi.org/10.2165/00003495-200969070-00008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181c07428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030665094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181c07428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030665094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e31818a3fee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031823990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e31818a3fee", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031823990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000195543.61123.1f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034449036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000195543.61123.1f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034449036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000195543.61123.1f", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034449036"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2044.2012.07197.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035646683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3182999672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037368438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3182999672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037368438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000542-200306000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037729307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000542-200306000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037729307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bja/aen037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042221890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.redar.2012.12.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042451419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000151159.55655.cb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042622078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000151159.55655.cb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042622078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000151159.55655.cb", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042622078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000095040.36648.f7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045669721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/01.ane.0000095040.36648.f7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045669721"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/bja/aep093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049673408"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181e33bd9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051909590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181e33bd9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051909590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1213/ane.0b013e3181e33bd9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051909590"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e3182342840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060338637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e3182342840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060338637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aln.0b013e3182342840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060338637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3310/hta14390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071139170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4172/2155-6148.1000140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072325938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077068040", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5694/j.1326-5377.2005.tb06846.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077068040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078727374", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0310057x1304100316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078727374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0310057x1304100316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078727374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0310057x1304100316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078727374"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: The objective of this analysis is to explore potential impact on operating room (OR) efficiency and incidence of residual neuromuscular blockade (RNMB) with use of sugammadex (Bridion\u2122, Merck & Co., Inc., Kenilworth, NJ USA) versus neostigmine for neuromuscular block reversal in Canada.\nMETHODS: A discrete event simulation (DES) model was developed to compare ORs using either neostigmine or sugammadex for NMB reversal over one month. Selected inputs included OR procedure and turnover times, hospital policies for paid staff overtime and procedural cancellations due to OR time over-run, and reductions in RNMB and associated complications with sugammadex use. Trials show sugammadex's impact on OR time and RNMB varies by whether full neuromuscular recovery (train-of-four ratio \u22650.9) is verified prior to extubation in the OR. Scenarios were therefore evaluated reflecting varied assumptions for neuromuscular reversal practices.\nRESULTS: With use of moderate neuromuscular block, when full neuromuscular recovery is verified prior to extubation (93 procedures performed with sugammadex, 91 with neostigmine), use of sugammadex versus neostigmine avoided 2.4 procedural cancellations due to OR time over-run and 33.5\u00a0h of paid staff overtime, while saving an average of 62\u00a0min per OR day. No difference was observed between comparators for these endpoints in the scenario when full neuromuscular recovery was not verified prior to extubation, however, per procedure risk of RNMB at extubation was reduced from 60% to 4% (reflecting 51 cases prevented), with associated reductions in risks of hypoxemia (12 cases avoided) and upper airway obstruction (23 cases avoided). Sugammadex impact in reversing deep neuromuscular block was evaluated in an exploratory analysis. When it was hypothetically assumed that 30\u00a0min of OR time were saved per procedure, the number of paid hours of staff over-time dropped from 84.1 to 32.0, with a 93% reduction in the per patient risk of residual blockade.\nCONCLUSIONS: In clinical practice within Canada, for the majority of patients currently managed with moderate neuromuscular block, the principal impact of substituting sugammadex for neostigmine is likely to be a reduction in the risk of residual blockade and associated complications. For patients maintained at a deep level of block to the end of the procedure, sugammadex is likely to both enhance OR efficiency and reduce residual block complications.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12871-016-0281-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024933", 
        "issn": [
          "1471-2253"
        ], 
        "name": "BMC Anesthesiology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada", 
    "pagination": "114", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "eb754d77c701930e89de6bda0d7bef71e0f2d3a3a49b1a5a3dd45e01b1be7a01"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27852231"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968535"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12871-016-0281-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1049426690"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12871-016-0281-3", 
      "https://app.dimensions.ai/details/publication/pub.1049426690"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70056_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12871-016-0281-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12871-016-0281-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12871-016-0281-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12871-016-0281-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12871-016-0281-3'


 

This table displays all metadata directly associated to this object as RDF triples.

238 TRIPLES      21 PREDICATES      74 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12871-016-0281-3 schema:about N0aa8b77b79db419d8bc90f2f9a770543
2 N182b5998380a4c878055097e5a63aa9a
3 N453d502672dd417a9eb611638ec99b97
4 N5216e2f78616482c8e76ebde39f54af5
5 N66f32f4b77cb4649abb0d54ba033961a
6 N7effe78b199f47f799449079e52a3a98
7 Nb58f8c0574734f259795ff82bdd8e97d
8 Nc2fc8d1feb8547378e786e2ae4891f65
9 Ne225837d1a45494b9cf24c26fbf108c5
10 Ne42a9f19697b4072bb82203d4a92bb9a
11 Nf4b4c23a582b45d1bec280b6ca83071b
12 anzsrc-for:11
13 anzsrc-for:1117
14 schema:author N15b191cfc3bd491fbf6a52da9b6500a5
15 schema:citation sg:pub.10.2165/00003495-200969070-00008
16 https://app.dimensions.ai/details/publication/pub.1077068040
17 https://app.dimensions.ai/details/publication/pub.1078727374
18 https://doi.org/10.1016/j.jval.2012.08.1364
19 https://doi.org/10.1016/j.redar.2012.12.011
20 https://doi.org/10.1093/bja/ael386
21 https://doi.org/10.1093/bja/aen037
22 https://doi.org/10.1093/bja/aep093
23 https://doi.org/10.1097/00000542-199301000-00010
24 https://doi.org/10.1097/00000542-200306000-00006
25 https://doi.org/10.1097/aco.0b013e32833a5413
26 https://doi.org/10.1097/aln.0b013e31818a3fee
27 https://doi.org/10.1097/aln.0b013e3182342840
28 https://doi.org/10.1097/eja.0000000000000010
29 https://doi.org/10.1097/eja.0b013e32833d56b7
30 https://doi.org/10.1097/mjt.0000000000000103
31 https://doi.org/10.1111/j.1365-2044.2005.04235.x
32 https://doi.org/10.1111/j.1365-2044.2012.07197.x
33 https://doi.org/10.1111/j.1399-6576.1997.tb04851.x
34 https://doi.org/10.1177/0310057x1304100316
35 https://doi.org/10.1213/01.ane.0000095040.36648.f7
36 https://doi.org/10.1213/01.ane.0000151159.55655.cb
37 https://doi.org/10.1213/01.ane.0000195543.61123.1f
38 https://doi.org/10.1213/01.ane.0000237296.57941.e7
39 https://doi.org/10.1213/ane.0b013e3181ac53c3
40 https://doi.org/10.1213/ane.0b013e3181c07428
41 https://doi.org/10.1213/ane.0b013e3181da832d
42 https://doi.org/10.1213/ane.0b013e3181e33bd9
43 https://doi.org/10.1213/ane.0b013e3182999672
44 https://doi.org/10.1590/s0104-11692011000500023
45 https://doi.org/10.3310/hta14390
46 https://doi.org/10.4103/0019-5049.108562
47 https://doi.org/10.4172/2155-6148.1000140
48 https://doi.org/10.5694/j.1326-5377.2005.tb06846.x
49 schema:datePublished 2016-12
50 schema:datePublishedReg 2016-12-01
51 schema:description BACKGROUND: The objective of this analysis is to explore potential impact on operating room (OR) efficiency and incidence of residual neuromuscular blockade (RNMB) with use of sugammadex (Bridion™, Merck & Co., Inc., Kenilworth, NJ USA) versus neostigmine for neuromuscular block reversal in Canada. METHODS: A discrete event simulation (DES) model was developed to compare ORs using either neostigmine or sugammadex for NMB reversal over one month. Selected inputs included OR procedure and turnover times, hospital policies for paid staff overtime and procedural cancellations due to OR time over-run, and reductions in RNMB and associated complications with sugammadex use. Trials show sugammadex's impact on OR time and RNMB varies by whether full neuromuscular recovery (train-of-four ratio ≥0.9) is verified prior to extubation in the OR. Scenarios were therefore evaluated reflecting varied assumptions for neuromuscular reversal practices. RESULTS: With use of moderate neuromuscular block, when full neuromuscular recovery is verified prior to extubation (93 procedures performed with sugammadex, 91 with neostigmine), use of sugammadex versus neostigmine avoided 2.4 procedural cancellations due to OR time over-run and 33.5 h of paid staff overtime, while saving an average of 62 min per OR day. No difference was observed between comparators for these endpoints in the scenario when full neuromuscular recovery was not verified prior to extubation, however, per procedure risk of RNMB at extubation was reduced from 60% to 4% (reflecting 51 cases prevented), with associated reductions in risks of hypoxemia (12 cases avoided) and upper airway obstruction (23 cases avoided). Sugammadex impact in reversing deep neuromuscular block was evaluated in an exploratory analysis. When it was hypothetically assumed that 30 min of OR time were saved per procedure, the number of paid hours of staff over-time dropped from 84.1 to 32.0, with a 93% reduction in the per patient risk of residual blockade. CONCLUSIONS: In clinical practice within Canada, for the majority of patients currently managed with moderate neuromuscular block, the principal impact of substituting sugammadex for neostigmine is likely to be a reduction in the risk of residual blockade and associated complications. For patients maintained at a deep level of block to the end of the procedure, sugammadex is likely to both enhance OR efficiency and reduce residual block complications.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree true
55 schema:isPartOf N8ef43b829e49473fa98dd04d57d1c676
56 Nf2675b2a814044d094af802cae6dfdba
57 sg:journal.1024933
58 schema:name A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
59 schema:pagination 114
60 schema:productId N1c1665c990c14e08b4f0bda9e7590512
61 Na4af818d9c534e66a1e8213d0a005071
62 Ncea01afa3d8a4e9ca38fbd5283b3898b
63 Nf8eafbebb1434d118f863be561916a43
64 Nfd22e18ca1b84c83900259a9e7b94072
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049426690
66 https://doi.org/10.1186/s12871-016-0281-3
67 schema:sdDatePublished 2019-04-11T12:41
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N0334b306f7fe42b2b6e6deafd6df8a1f
70 schema:url https://link.springer.com/10.1186%2Fs12871-016-0281-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N0334b306f7fe42b2b6e6deafd6df8a1f schema:name Springer Nature - SN SciGraph project
75 rdf:type schema:Organization
76 N0aa8b77b79db419d8bc90f2f9a770543 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name gamma-Cyclodextrins
78 rdf:type schema:DefinedTerm
79 N15b191cfc3bd491fbf6a52da9b6500a5 rdf:first sg:person.01254476051.49
80 rdf:rest N270eed2c85ce45328b29842f21af128a
81 N182b5998380a4c878055097e5a63aa9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Canada
83 rdf:type schema:DefinedTerm
84 N1c1665c990c14e08b4f0bda9e7590512 schema:name readcube_id
85 schema:value eb754d77c701930e89de6bda0d7bef71e0f2d3a3a49b1a5a3dd45e01b1be7a01
86 rdf:type schema:PropertyValue
87 N270eed2c85ce45328b29842f21af128a rdf:first sg:person.0702677613.77
88 rdf:rest Nf15150f8f2ee4466a5273a4b26e055a5
89 N453d502672dd417a9eb611638ec99b97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Operating Rooms
91 rdf:type schema:DefinedTerm
92 N5216e2f78616482c8e76ebde39f54af5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Neostigmine
94 rdf:type schema:DefinedTerm
95 N66f32f4b77cb4649abb0d54ba033961a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Randomized Controlled Trials as Topic
97 rdf:type schema:DefinedTerm
98 N7effe78b199f47f799449079e52a3a98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Organizational Policy
100 rdf:type schema:DefinedTerm
101 N8ef43b829e49473fa98dd04d57d1c676 schema:issueNumber 1
102 rdf:type schema:PublicationIssue
103 Na4af818d9c534e66a1e8213d0a005071 schema:name dimensions_id
104 schema:value pub.1049426690
105 rdf:type schema:PropertyValue
106 Nac3cdd1a2f4b4808bccd55b8be1c321b rdf:first sg:person.013376246031.79
107 rdf:rest rdf:nil
108 Nb58f8c0574734f259795ff82bdd8e97d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Humans
110 rdf:type schema:DefinedTerm
111 Nc2fc8d1feb8547378e786e2ae4891f65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Neuromuscular Blockade
113 rdf:type schema:DefinedTerm
114 Ncea01afa3d8a4e9ca38fbd5283b3898b schema:name pubmed_id
115 schema:value 27852231
116 rdf:type schema:PropertyValue
117 Ne225837d1a45494b9cf24c26fbf108c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Computer Simulation
119 rdf:type schema:DefinedTerm
120 Ne42a9f19697b4072bb82203d4a92bb9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Sugammadex
122 rdf:type schema:DefinedTerm
123 Nf15150f8f2ee4466a5273a4b26e055a5 rdf:first sg:person.012600665431.18
124 rdf:rest Nac3cdd1a2f4b4808bccd55b8be1c321b
125 Nf2675b2a814044d094af802cae6dfdba schema:volumeNumber 16
126 rdf:type schema:PublicationVolume
127 Nf4b4c23a582b45d1bec280b6ca83071b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Efficiency, Organizational
129 rdf:type schema:DefinedTerm
130 Nf8eafbebb1434d118f863be561916a43 schema:name nlm_unique_id
131 schema:value 100968535
132 rdf:type schema:PropertyValue
133 Nfd22e18ca1b84c83900259a9e7b94072 schema:name doi
134 schema:value 10.1186/s12871-016-0281-3
135 rdf:type schema:PropertyValue
136 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
137 schema:name Medical and Health Sciences
138 rdf:type schema:DefinedTerm
139 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
140 schema:name Public Health and Health Services
141 rdf:type schema:DefinedTerm
142 sg:journal.1024933 schema:issn 1471-2253
143 schema:name BMC Anesthesiology
144 rdf:type schema:Periodical
145 sg:person.01254476051.49 schema:affiliation https://www.grid.ac/institutes/grid.417993.1
146 schema:familyName Insinga
147 schema:givenName Ralph P.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254476051.49
149 rdf:type schema:Person
150 sg:person.012600665431.18 schema:affiliation https://www.grid.ac/institutes/grid.292545.d
151 schema:familyName Goyette
152 schema:givenName Alexandra
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012600665431.18
154 rdf:type schema:Person
155 sg:person.013376246031.79 schema:affiliation https://www.grid.ac/institutes/grid.292545.d
156 schema:familyName Galarneau
157 schema:givenName André
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013376246031.79
159 rdf:type schema:Person
160 sg:person.0702677613.77 schema:affiliation https://www.grid.ac/institutes/grid.292545.d
161 schema:familyName Joyal
162 schema:givenName Cédric
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702677613.77
164 rdf:type schema:Person
165 sg:pub.10.2165/00003495-200969070-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028465269
166 https://doi.org/10.2165/00003495-200969070-00008
167 rdf:type schema:CreativeWork
168 https://app.dimensions.ai/details/publication/pub.1077068040 schema:CreativeWork
169 https://app.dimensions.ai/details/publication/pub.1078727374 schema:CreativeWork
170 https://doi.org/10.1016/j.jval.2012.08.1364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023587552
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/j.redar.2012.12.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042451419
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1093/bja/ael386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011356812
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1093/bja/aen037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042221890
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1093/bja/aep093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049673408
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1097/00000542-199301000-00010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025374245
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1097/00000542-200306000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037729307
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1097/aco.0b013e32833a5413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016295960
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1097/aln.0b013e31818a3fee schema:sameAs https://app.dimensions.ai/details/publication/pub.1031823990
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1097/aln.0b013e3182342840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060338637
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1097/eja.0000000000000010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002676609
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1097/eja.0b013e32833d56b7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011166407
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1097/mjt.0000000000000103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025735765
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1111/j.1365-2044.2005.04235.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001422224
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1111/j.1365-2044.2012.07197.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1035646683
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1111/j.1399-6576.1997.tb04851.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009014306
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1177/0310057x1304100316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078727374
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1213/01.ane.0000095040.36648.f7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045669721
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1213/01.ane.0000151159.55655.cb schema:sameAs https://app.dimensions.ai/details/publication/pub.1042622078
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1213/01.ane.0000195543.61123.1f schema:sameAs https://app.dimensions.ai/details/publication/pub.1034449036
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1213/01.ane.0000237296.57941.e7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012778108
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1213/ane.0b013e3181ac53c3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005859806
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1213/ane.0b013e3181c07428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030665094
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1213/ane.0b013e3181da832d schema:sameAs https://app.dimensions.ai/details/publication/pub.1013533672
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1213/ane.0b013e3181e33bd9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051909590
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1213/ane.0b013e3182999672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037368438
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1590/s0104-11692011000500023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012264683
223 rdf:type schema:CreativeWork
224 https://doi.org/10.3310/hta14390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071139170
225 rdf:type schema:CreativeWork
226 https://doi.org/10.4103/0019-5049.108562 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005043142
227 rdf:type schema:CreativeWork
228 https://doi.org/10.4172/2155-6148.1000140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072325938
229 rdf:type schema:CreativeWork
230 https://doi.org/10.5694/j.1326-5377.2005.tb06846.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1077068040
231 rdf:type schema:CreativeWork
232 https://www.grid.ac/institutes/grid.292545.d schema:alternateName Merck (Canada)
233 schema:name Department of Health Economics and Observational Research, 16750 Transcanada Highway, Merck Canada, H9H 4M7, Kirkland, Québec, Canada
234 Department of Medical Affairs, 16750 Transcanada Highway, Merck Canada, H9H 4M7, Kirkland, Québec, Canada
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.417993.1 schema:alternateName MSD (United States)
237 schema:name Department of Predictive & Economic Modeling, Merck & Co., Inc, PO Box 1000, UG1CD-32, 19454-1099, North Wales, PA, USA
238 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...